GGrantIndex
Sort

51,593 grants matching hepatitis

(PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer

$563,374
Amy Caroline Justice · Yale University · R01 · FY2016 · CA

Health Consequences Amoung DWI Offenders

$563,320
Buffalo State College · R01 · FY2003 · AA

GENE THERAPY FOR HEMOPHILIA A AND B

$563,316
Salk Institute For Biological Studies · R01 · FY2001 · HL

Defining the Role of Host Factors in Ebola Virus RNA Synthesis

$563,251
Douglas J. Lacount · Washington University · P01 · FY2019 · AI

Defining the Role of Host Factors in Ebola Virus RNA Synthesis

$563,250
Douglas J. Lacount · Washington University · P01 · FY2020 · AI

Administrative Core

$563,243
Craig J McClain · University Of Louisville · P20 · FY2018 · GM

Moderately CHO-restricted diet as treatment targeting improvement in hepatic lipid and insulin sensitivity in adolescents with NAFLD

$563,124
Amy Miskimon Goss · University Of Alabama At Birmingham · R01 · FY2024 · DK

Complement Mediated Injury in Allograft Rejection

$563,122
William M Baldwin · Johns Hopkins University · R01 · FY2007 · AI

Phase I/II Trials of Silymarin for Chronic Liver Diseases Data Coordinating Cente

$563,105
Steven H. Belle · University Of Pittsburgh At Pittsburgh · U01 · FY2008 · AT

Metabolic inflexibility is related to elevated muscle anaerobic glycolysis

$563,101
Joseph A Houmard · East Carolina University · R01 · FY2022 · DK

Project 1 - Changes in Gut Microbiome and related Metabolome Across Trajectory of Alzheimer's Disease

$563,038
Rima F Kaddurah-Daouk · Duke University · U19 · FY2020 · AG

A Natural History Study of Buprenorphine Diversion, Self-Treatment, and Use of Drug Abuse Treatment Services

$563,029
Raminta Daniulaityte · Wright State University · R01 · FY2016 · DA

Integration of Feeding and Glucose Metabolism by the Circadian Gene Network

$563,011
Joseph T Bass · Northwestern University At Chicago · R01 · FY2011 · DK

Developing Anti-viral Ribozymes to Suppress Arboviruses in Transgenic Mosquitoes

$563,007
Malcolm J. Fraser · University Of Notre Dame · R01 · FY2014 · AI

Developing Anti-viral Ribozymes to Suppress Arboviruses in Transgenic Mosquitoes

$563,007
Malcolm J. Fraser · University Of Notre Dame · R01 · FY2016 · AI

Developing Anti-viral Ribozymes to Suppress Arboviruses in Transgenic Mosquitoes

$563,007
Malcolm J. Fraser · University Of Notre Dame · R01 · FY2012 · AI

Developing Anti-viral Ribozymes to Suppress Arboviruses in Transgenic Mosquitoes

$563,007
Malcolm J. Fraser · University Of Notre Dame · R01 · FY2015 · AI

HBV Capsid Effectors

$563,003
Raymond F. Schinazi · Emory University · R01 · FY2017 · AI

Health Literacy Assessment and Intervention to Reduce Disparities: FLIGHT/VIDAS II

$562,926
Raymond L Ownby · Nova Southeastern University · R01 · FY2017 · MD

Amphiphilic Polycations for Nucleic Acid Delivery

$562,847
David B Rozema · Mirus Bio Corporation · R44 · FY2008 · GM

Neutralizing Antibodies to Hepatitis C

$562,782
Stanford University · R01 · FY2004 · HL

HIV Antiretroviral Therapy and Hepatic Injury

$562,690
Kenneth E Sherman · University Of Cincinnati · R01 · FY2016 · AI

Evaluation of a Hepatitis B Outreach Intervention for Cambodians

$562,642
Victoria M Taylor · Fred Hutchinson Cancer Research Center · R01 · FY2009 · CA

Regulation of lipid metabolism in pulmonary Type 2 cells

$562,555
Itsaso Garcia-Arcos · Suny Downstate Medical Center · R01 · FY2022 · HL

Risk Reduction for Young African American IDUs

$562,493
Tulane University Of Louisiana · R01 · FY2001 · DA